Fagron NV
XBRU:FAGR

Watchlist Manager
Fagron NV Logo
Fagron NV
XBRU:FAGR
Watchlist
Price: 18.24 EUR -0.33% Market Closed
Market Cap: 1.3B EUR
Have any thoughts about
Fagron NV?
Write Note

Fagron NV
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fagron NV
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Fagron NV
XBRU:FAGR
Revenue
€763m
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
N/A
No Stocks Found

Fagron NV
Glance View

Market Cap
1.3B EUR
Industry
Health Care

Fagron NV engages in the development, marketing, and distribution of healthcare products and services. The company is headquartered in Nazareth, Oost-Vlaanderen and currently employs 3,061 full-time employees. The company went IPO on 2007-10-05. The company operates as a research and development (R&D) scientific pharmaceutical compounding supplier and operates through four segments: The Fagron Specialty Pharma Services segment comprises personalized medication that is produced in the Company's compounding facilities; the Fagron Trademarks segment encompasses concepts and formulations developed by the Company's research and development (R&D) team; Fagron Essentials comprises pharmaceutical raw materials, equipment and supplies for pharmacies, and the HL Technology segment includes the development and production of precision components and orthopedic tools for dental and medical professionals.

FAGR Intrinsic Value
26.29 EUR
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Fagron NV's Revenue?
Revenue
763m EUR

Based on the financial report for Dec 31, 2023, Fagron NV's Revenue amounts to 763m EUR.

What is Fagron NV's Revenue growth rate?
Revenue CAGR 5Y
10%

Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Fagron NV have been 11% over the past three years , 10% over the past five years .

Back to Top